De Zhou

826 total citations
53 papers, 472 citations indexed

About

De Zhou is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, De Zhou has authored 53 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 16 papers in Immunology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in De Zhou's work include Immune Cell Function and Interaction (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Acute Myeloid Leukemia Research (13 papers). De Zhou is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Acute Myeloid Leukemia Research (13 papers). De Zhou collaborates with scholars based in China, Sweden and Singapore. De Zhou's co-authors include Xiujin Ye, Lixia Zhu, Wanzhuo Xie, Jingjing Zhu, Mixue Xie, Mingyu Zhu, Jie Jin, Xianbo Huang, Rongrong Chen and T. Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

De Zhou

50 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
De Zhou China 14 207 112 103 102 99 53 472
Rongfu Zhou China 14 258 1.2× 41 0.4× 102 1.0× 142 1.4× 104 1.1× 63 545
Ivan Moiseev Russia 13 336 1.6× 143 1.3× 98 1.0× 209 2.0× 84 0.8× 149 611
Jong‐Wook Lee South Korea 16 343 1.7× 89 0.8× 24 0.2× 96 0.9× 84 0.8× 40 542
Ho Jin Shin South Korea 12 116 0.6× 91 0.8× 106 1.0× 133 1.3× 84 0.8× 46 457
Aiming Pang China 13 259 1.3× 118 1.1× 16 0.2× 79 0.8× 109 1.1× 103 573
Kentaro Narita Japan 15 257 1.2× 43 0.4× 179 1.7× 246 2.4× 176 1.8× 96 677
Olga Aleinikova Belarus 11 220 1.1× 80 0.7× 26 0.3× 86 0.8× 110 1.1× 50 517
Hisham Abdel‐Azim United States 17 277 1.3× 277 2.5× 42 0.4× 275 2.7× 294 3.0× 68 966
Shreyans Gandhi United Kingdom 13 411 2.0× 186 1.7× 21 0.2× 53 0.5× 59 0.6× 34 580
Shambavi Richard United States 15 353 1.7× 114 1.0× 33 0.3× 394 3.9× 268 2.7× 64 708

Countries citing papers authored by De Zhou

Since Specialization
Citations

This map shows the geographic impact of De Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Zhou more than expected).

Fields of papers citing papers by De Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Zhou. The network helps show where De Zhou may publish in the future.

Co-authorship network of co-authors of De Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of De Zhou. A scholar is included among the top collaborators of De Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De Zhou. De Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, De, Xianbo Huang, Lixia Zhu, et al.. (2025). Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China. Blood. 146(3). 318–327. 2 indexed citations
3.
You, Liangshun, Yi Liu, Wenyuan Mai, et al.. (2024). Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study. European Journal of Cancer. 202. 113979–113979. 3 indexed citations
4.
Yang, Meifang, et al.. (2023). Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review. Journal of Zhejiang University SCIENCE B. 24(12). 1159–1164. 2 indexed citations
5.
Pan, Jiajia, Yile Zhou, Liping Mao, et al.. (2023). Gilteritinib‐based combination therapy in adult relapsed/refractory FLT3 ‐mutated acute myeloid leukaemia. British Journal of Haematology. 204(3). 861–870. 1 indexed citations
6.
Shen, Huafei, Yuanfei Shi, Yanchun Zhao, et al.. (2023). Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients. Frontiers in Oncology. 13. 1172623–1172623. 3 indexed citations
7.
8.
Zhu, Lixia, De Zhou, Li Li, et al.. (2023). Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis. Annals of Hematology. 102(9). 2301–2308. 4 indexed citations
9.
Li, Li, Rongrong Chen, De Zhou, et al.. (2022). The efficacy and cardiac toxicity of different‐dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma. Cancer Medicine. 12(4). 4184–4194. 6 indexed citations
10.
Zhu, Lixia, Rongrong Chen, Lulu Wang, et al.. (2022). A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia. Supportive Care in Cancer. 30(8). 7031–7038. 12 indexed citations
11.
Huang, Xianbo, De Zhou, Xiujin Ye, & Jie Jin. (2021). Construction of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in acute myeloid leukemia. Bosnian Journal of Basic Medical Sciences. 22(4). 608–628. 16 indexed citations
12.
Chen, Rongrong, Lixia Zhu, Lulu Wang, et al.. (2021). Synchronous diagnosis and treatment of acute myeloid leukemia and chronic lymphocytic leukemia: Two case reports. World Journal of Clinical Cases. 9(30). 9144–9150. 2 indexed citations
13.
Zhu, Lixia, Lulu Wang, Yuping Zhang, et al.. (2021). Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study. BMC Infectious Diseases. 21(1). 723–723. 14 indexed citations
14.
Zhang, Yan, Yuanfei Shi, Huafei Shen, et al.. (2021). The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma. Cancer Cell International. 21(1). 573–573. 5 indexed citations
15.
Li, Xueying, Yile Zhou, Yi Zhang, et al.. (2021). Coagulation profile in newly diagnosed T-cell acute lymphoblastic leukemia. Thrombosis Research. 203. 69–71. 3 indexed citations
16.
Lou, Yinjun, Jingjing Zhu, Huafei Shen, et al.. (2020). Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia. Frontiers in Oncology. 10. 577796–577796. 12 indexed citations
17.
Zhou, De, Lixia Zhu, Mixue Xie, et al.. (2018). Factors Affecting Early Death and Survival of Patients With Acute Promyelocytic Leukemia Treated With ATRA-Based Therapy Regimens. Clinical Lymphoma Myeloma & Leukemia. 19(1). e63–e70. 13 indexed citations
18.
Lu, Yunhao, De Zhou, T. Wang, Shengyuan A. Yang, & J.Z. Jiang. (2016). Topological Properties of Atomic Lead Film with Honeycomb Structure. Scientific Reports. 6(1). 21723–21723. 26 indexed citations
19.
Li, Li, Lixia Zhu, Yungui Wang, et al.. (2016). Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene. Oncology Letters. 13(1). 105–110. 7 indexed citations
20.
Zhou, Meng, Shanshan Ma, De Zhou, et al.. (2016). Clinical Observation on Hemogram Variation of Allogeneic Donors from Chinese Population for Peripheral Hematopoietic Stem Cell Collection. Stem Cells and Development. 25(10). 798–802. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongfu Zhou Breakdown of academic impact, for papers by Ivan Moiseev Breakdown of academic impact, for papers by Jong‐Wook Lee Breakdown of academic impact, for papers by Ho Jin Shin Breakdown of academic impact, for papers by Aiming Pang Breakdown of academic impact, for papers by Kentaro Narita Breakdown of academic impact, for papers by Olga Aleinikova Breakdown of academic impact, for papers by Hisham Abdel‐Azim Breakdown of academic impact, for papers by Shreyans Gandhi Breakdown of academic impact, for papers by Shambavi Richard
Rankless by CCL
2026